Found 0 matching trials
A Long Term Follow-up Study of TScan TCR-T Products N/A The purpose of this Long-Term Follow-Up (LTFU) study is to monitor particip...
Show More Learn More & Join Trial
Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions PHASE2 Background:
Human papillomavirus (HPV) can cause vulvar high-grade squamou...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer PHASE2 This randomized phase II trial studies how well nivolumab works with or wit...
Show More Location
Sutter Auburn Faith Hospital
Learn More & Join Trial
TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia NA This is a clinical study of TAA6 cell injection in the treatment of patient...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial
Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies PHASE1 This single arm pilot phase I study with safety run-in is designed to estim...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers PHASE1 The primary objectives of Phase 1A are to evaluate the safety of KITE-718, ...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors PHASE1 This is an early phase trial designed to evaluate the safety, tolerability,...
Show More Learn More & Join Trial
Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials PHASE2 This screening study is intended to determine preliminary eligibility of pa...
Show More Location
GSK Investigational Site
Learn More & Join Trial
TCR-engineered T Cells (NW-101C) in Patients With Solid Malignant Tumors PHASE1 This clinical trial is a prospective, dose-escalation, multicenter, single-...
Show More Location
Beijing Cancer hosptial
Learn More & Join Trial
Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer PHASE1 This phase I/II trial studies the side effects of gene-modified immune cell...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial